Hemopropin Ointment recalled over manufacturing violations
- Recall date
- April 9, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Apipharma recalls Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o,…
- Recall number
- D-0375-2025
- FDA classification
- Class II
- Brand / firm
- Apipharma
- Sold / distributed
- AZ
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ UPC 3 858882 103534 and UPC 3 858882 101318
Get recall alerts
Free email alert whenever Apipharma has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Apipharma